4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
M3, Inc. (2413) operates in the Health Information Services industry and is headquartered in Tokyo, Japan with about 17,010 employees. Its market capitalization is roughly JPY 1.03 trillion. In the fiscal year ended 2026-03-31, 2413 reported JPY 351.4B in revenue and JPY 49.1B in net income.
M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 351.4B | JPY 284.9B | JPY 238.9B | JPY 230.8B | — |
| Gross Profit | JPY 175.8B | JPY 154.4B | JPY 140.5B | JPY 135.2B | — |
| Operating Income (EBIT) | JPY 71.1B | JPY 60.3B | JPY 63.0B | JPY 70.5B | — |
| Net Income | JPY 49.1B | JPY 40.5B | JPY 45.3B | JPY 49.0B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Dividends Paid | (JPY 14.3B) | (JPY 12.9B) | (JPY 10.9B) | (JPY 8.1B) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | JPY 637.4B | JPY 581.7B | JPY 490.8B | JPY 400.6B |
| Total Liabilities | JPY 190.7B | JPY 168.9B | JPY 124.1B | JPY 91.1B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2413 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms